Bioglyco ApS: Financial statements 2021
CVR: 39676664
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
Bioglyco ApS (CVR 39676664) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,250 and a net result of DKK -2,250 compared with DKK -2,250 the year before. Equity in the 2021 report amounted to DKK 4,255. The solvency ratio was 12.4%.
- Gross Profit
- DKK -2,250
- Profit/Loss
- DKK -2,250
- Equity
- DKK 4,255
- Total Assets
- DKK 34,392
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2 t. | -2 t. | 4 t. | - |
| 2020 | - | -2 t. | -2 t. | 7 t. | - |
| 2019 | - | -6 t. | -6 t. | 9 t. | - |
Official annual report
Find more companies like Bioglyco ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 14, 2021, the company changed its name from Bioglyco IVS to Bioglyco ApS.
About Bioglyco ApS
Bioglyco ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Bioglyco IVS. The management consists of Giuseppe Palmisano. The company is owned by Giuseppe Palmisano. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK -2,625 the year before. Equity in the 2025 report amounted to DKK 17,692.